Fast & Discreet Worldwide Shipping•Lab Tested for Purity & Potency•100% Quality Guaranteed
Newweight Peptide
Retatrutide
Triple-agonist next-generation metabolic peptide.
$155.0010 mg vial
Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors — currently producing the most dramatic body-composition outcomes seen in metabolic peptide research.
- 99%+ purity
- Third-party tested
- Cold-chain shipping
- Discreet worldwide delivery
Key Research Areas
- Aggressive fat-mass reduction
- Improved metabolic markers
- Greater energy expenditure
- Sustained appetite control
Mechanism
Stimulates GLP-1 and GIP for appetite and glucose control, while the glucagon arm increases energy expenditure and supports hepatic fat reduction.
Reference Protocol
Typical research protocol: start 1–2 mg weekly and increase slowly every 4 weeks.
For laboratory and research use only. Not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. All protocols are reference summaries provided for educational purposes — always consult a qualified healthcare professional.
You may also like